Market Place
Sourcing Support
OrganOx & eGenesis Announce Liver Failure Co-Development Deal
12 Nov 2024 //
GLOBENEWSWIRE
Natco Pharma acquires 40 million shares in eGenesis Inc
04 Sep 2024 //
ECONOMICTIMES
eGenesis and PorMedTec Announce Production of Engineered Porcine Donors
13 Feb 2024 //
BUSINESSWIRE
eGenesis and OrganOx Announce Use of a Genetically Engineered Porcine Liver
18 Jan 2024 //
BUSINESSWIRE
eGenesis Presents Data Demonstrating Recipient Survival with Porcine Kidneys
26 Oct 2023 //
GLOBENEWSWIRE
eGenesis Announces Publication Data Demonstrating Survival with Porcine Kidneys
11 Oct 2023 //
GLOBENEWSWIRE
eGenesis brings kidney xenotransplants closer to the clinic
11 Oct 2023 //
ENDPTS
eGenesis Announces Publication in Nature Characterizing Renal Physiology
13 Jun 2023 //
GLOBENEWSWIRE
eGenesis Presents Data on Preclinical Kidney Xenotransplantation
05 Jun 2023 //
GLOBENEWSWIRE
eGenesis Announces Knut Niss as Chief Technology Officer
24 Jan 2023 //
GLOBENEWSWIRE
eGenesis and Eledon Announce Collaboration for Use of Tegoprubart
09 Jan 2023 //
GLOBENEWSWIRE
Former eGenesis CEO joins vTv as it tries to make a comeback; & MORE
29 Jul 2022 //
ENDPTS
eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer
19 Apr 2022 //
GLOBENEWSWIRE
En route to xenotransplantation trial, eGenesis taps CEO weeks after CMO hire
19 Apr 2022 //
ENDPTS
eGenesis Appoints Eliezer Katz, M.D., FACS, as Chief Medical Officer
04 Apr 2022 //
GLOBENEWSWIRE
eGenesis says Research Collaboration with the University of Miami
09 Mar 2022 //
GLOBENEWSWIRE
eGenesis Strengthens Production Capabilities with Acquisition of ICBiotec
20 May 2020 //
EGENESISBIO
eGenesis Strengthens Production Capabilities with Acquisition of ICBiotec
20 May 2020 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.